ZUMZ 35.62 Zumiez Inc $ZUMZ Hit a 52 week high of 36.15

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 4:00 PM

ZUMZ 35.62 Zumiez Inc $ZUMZ Hit a 52 week high of 36.15 Closing the day 09:44 at 35.62 +0.20 +0.56% With a day low of 35.70 and a total volume of 10,971.

ZUMZ Recent Posts: http://investorshangout.com/Zumiez-Inc-ZUMZ-55978/

ZUMZ Zumiez Inc Recent Headline News

15.5% Return Seen to Date on SmarTrend Zumiez Call (ZUMZ)
Comtex SmarTrend(R) - Fri Nov 14, 9:52AM CST
SmarTrend identified an Uptrend for Zumiez (NASDAQ:ZUMZ) on October 10th, 2014 at $31.08. In approximately 1 month, Zumiez has returned 15.49% as of today's recent price of $35.89.
ZUMZ: 35.48 (+0.06)

Sally Beauty Q4 Earnings Miss by a Penny, Revenues In Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:20AM CST
Sally Beauty (SBH), the specialty retailer of professional beauty supplies, posted fourth-quarter fiscal 2014 adjusted earnings of 39 cents a share that missed the Zacks Consensus Estimate by a penny.
BEBE: 2.62 (+0.23), ZUMZ: 35.48 (+0.06), SBH: 30.22 (-0.20), ULTA: 123.85 (-0.07)

Nordstrom Reports Strong Q3 Earnings, Updates Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:00AM CST
Nordstrom Inc's (JWN) third-quarter earnings of 73 cents per share came ahead of the Zacks Consensus Estimate of 71 cents and in line with company's expectations.
BEBE: 2.62 (+0.23), ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), JWN: 74.31 (+1.06)

Zacks Industry Outlook Highlights: Zumiez, L Brands, Buckle, Gap and Fred's
PR Newswire - Wed Nov 12, 8:30AM CST
Today, Zacks Equity Research discusses the Retail, including Zumiez Inc. (Nasdaq:ZUMZ-Free Report), L Brands Inc. (NYSE:LB-Free Report), Buckle Inc. (NYSE:BKE-Free Report), Gap Inc. (NYSE:GPS-Free Report) and Fred's Inc. (Nasdaq:FRED-Free Report).
ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), GPS: 39.45 (+0.21), BKE: 49.66 (-0.91)

Buckle's Shares Fall Marginally as October Comps Slip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 5:23PM CST
Shares of The Buckle, Inc (BKE) witnessed a marginal decline of roughly 1.2%, as October comps fell 4.4%.
ZUMZ: 35.48 (+0.06), GPS: 39.45 (+0.21), BKE: 49.66 (-0.91), RAD: 5.52 (+0.13)

Will Tyco (TYC) Miss on Q4 Earnings Despite Strengths? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 11:30AM CST
Tyco International Ltd. (TYC) is scheduled to report its fourth-quarter fiscal 2014 results before the market opens on Nov 13.
ZUMZ: 35.48 (+0.06), TYC: 42.34 (-0.10), MW: 46.72 (+0.03), KR: 57.65 (-0.74)

Strong Holiday Season Likely for Retailers? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:54AM CST
Strong Holiday Season Likely for Retailers? - Industry Outlook
CATO: 37.72 (unch), ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), FRED: 16.35 (-0.17), GPS: 39.45 (+0.21), BKE: 49.66 (-0.91), WAG: 66.89 (-0.07), RAD: 5.52 (+0.13), SMRT: 13.40 (+0.06)

Strong Holiday Season Likely for Retailers? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:54AM CST
Strong Holiday Season Likely for Retailers? - Zacks Analyst Interviews
CATO: 37.72 (unch), ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), FRED: 16.35 (-0.17), GPS: 39.45 (+0.21), BKE: 49.66 (-0.91), WAG: 66.89 (-0.07), RAD: 5.52 (+0.13), SMRT: 13.40 (+0.06)

Cato's (CATO) Key Sales Metrics for October Improved 2% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 5:45PM CST
Cato Corporation (CATO) posted yet another month of improved comparable-store sales (comps) for the 4 weeks ended Nov 1, 2014, registering an increase of 2%.
ZUMZ: 35.48 (+0.06), CATO: 37.72 (unch), LB: 77.54 (+0.49), COST: 138.25 (-0.46)

L Brands' October Comparable Sales Grow on Innovations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 3:00PM CST
Shares of L Brands, Inc. (LB) witnessed a marginal growth of roughly 1%, following comparable-store sales (comps) results for the four weeks ended Nov 1, 2014, faring better than analysts' expectations.
ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), HBI: 109.58 (+0.27), RAD: 5.52 (+0.13)

Will Wal-Mart (WMT) Miss Q3 Earnings on Higher Costs? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:30PM CST
Wal-Mart Stores Inc. (WMT) is set to report third-quarter fiscal 2015 results, before the opening bell on Nov 13. Last quarter, this retail giant posted in-line results.
ZUMZ: 35.48 (+0.06), AMZN: 328.02 (+11.54), KR: 57.65 (-0.74), WMT: 82.95 (+0.01)

Will Kohl's Corp. (KSS) Miss Earnings on Sluggish Comps? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:10PM CST
Kohl's Corporation (KSS) is set to report third-quarter fiscal 2014 results before the opening bell on Nov 13. Last quarter, this specialty retailer posted a positive surprise of 5.61%.
ZUMZ: 35.48 (+0.06), KSS: 57.06 (+0.99), MW: 46.74 (+0.05), KR: 57.65 (-0.74)

Will ADT Corporation (ADT) Surprise on Q4 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 12:10PM CST
The ADT Corporation (ADT) is scheduled to report its fourth-quarter fiscal 2014 results before the market opens on Nov 12.
ZUMZ: 35.48 (+0.06), MW: 46.74 (+0.05), KR: 57.65 (-0.74), ADT: 35.87 (+0.85)

Can Fossil Inc. (FOSL) Keep the Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 5:00PM CST
Fossil Inc. (FOSL) is set to report third-quarter 2014 results after the market closes on Nov 11.
ZUMZ: 35.48 (+0.06), FOSL: 108.54 (-1.27), MW: 46.74 (+0.05), KR: 57.65 (-0.74)

Bebe Stores Rises on Narrower-than-Expected Loss in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:30AM CST
Shares of Bebe Stores Inc. (BEBE) grew 5% in the after-hour trading session yesterday, after the company reported narrower-than-expected first-quarter fiscal 2015 results.
BEBE: 2.62 (+0.23), ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), CTRN: 22.66 (-0.03)

Kate Spade Up on Strong Q3 Earnings & Upbeat FY14 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:20AM CST
Shares of Kate Spade & Company (KATE) gained 17.9% in the yesterday's trading session after the company posted strong third-quarter 2014 results and provided an upbeat guidance for the full-year.
ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), CTRN: 22.66 (-0.03), KATE: 29.01 (+0.21)

Zumiez Shares Up 12.0% Since SmarTrend's Buy Recommendation (ZUMZ)
Comtex SmarTrend(R) - Fri Nov 07, 9:30AM CST
SmarTrend identified an Uptrend for Zumiez (NASDAQ:ZUMZ) on October 10th, 2014 at $31.08. In approximately 4 weeks, Zumiez has returned 12.02% as of today's recent price of $34.81.
ZUMZ: 35.48 (+0.06)

Lull At The Mall Just Retail's Calm Before Christmas?
at Investor's Business Daily - Thu Nov 06, 5:22PM CST
Shoppers spent less freely in October as they took a break heading into the holiday season's traditional buying frenzy, leading to slow mall traffic and mixed sales reports from retailers Thursday. The jury is still out on how retailers will fare...
ZUMZ: 35.48 (+0.06), M: 62.06 (+0.49), WMT: 82.96 (+0.02), KORS: 72.10 (+1.36), FIVE: 42.78 (+0.72), RAD: 5.51 (+0.12), LB: 77.54 (+0.49), JWN: 74.32 (+1.07), COST: 138.25 (-0.46), GPS: 39.45 (+0.21), KATE: 29.01 (+0.21), AAPL: 114.05 (+1.23), BKE: 49.66 (-0.91), WAG: 66.89 (-0.07), SMRT: 13.40 (+0.06)

Zumiez October Key Metrics Up 3.1% Despite Slowdown - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:21PM CST
Zumiez Inc. (ZUMZ) reported a 3.1% rise in comps for the four weeks ended Nov 1, 2014, much ahead of the 1.2% increase reported for the four weeks ended Nov 2013.
ZUMZ: 35.48 (+0.06), LB: 77.54 (+0.49), CTRN: 22.66 (-0.03), ARO: 2.99 (+0.12)

Zumiez same-store sales: +3.1%
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:04AM CST

ZUMZ: 35.48 (+0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 158

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...